Vaxcell-Bio Therapeutics Co. Ltd (323990.KQ) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · South Korea
Price
4,020.00 KRW
Market cap
93.16 bn KRW
P/E (2025)
–
P/S (2025)
13.20
Dividend yield
0.00 %
Net margin
-189.05 %
Return on equity (ROE)
-21.82 %
Return on assets (ROA)
-19.94 %
Vaxcell-Bio Therapeutics Co. Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 1.90 bn KRW | 7.06 bn KRW |
| Gross profit | 364.77 m KRW | 893.11 m KRW |
| Operating income | -15.05 bn KRW | -15.49 bn KRW |
| EBIT | -10.40 bn KRW | -13.12 bn KRW |
| Net income | -10.62 bn KRW | -13.34 bn KRW |
| Diluted EPS – continuing operations | -463.71 KRW | -575.65 KRW |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Vaxcell-Bio Therapeutics Co. Ltd
Vaxcell-Bio Therapeutics Co., Ltd. develops and anticancer immunotherapy products in South Korea. The company was founded in 2010 and is headquartered in Hwasun-eup, South Korea.
More stocks
- Smothong Group Public Company Limited (SMO.BK)
- PT Buana Artha Anugerah Tbk (STAR.JK)
- Brightek Optoelectronic Co Ltd (5244.TW)
- YTN Co.Ltd (040300.KQ)
- ChainSea Information Integration Co.,Ltd. (6898.TWO)
- RingNet Co. Ltd (042500.KQ)
- Genii Ideas Co., Ltd. (7631.TW)
- Cheetah Mobile Inc (CMCM)
- C-Media Electronics (6237.TWO)
- General Plastic Industrial Co Ltd (6128.TW)
- Starflex Public Company Limited (SFLEX.BK)
- Hwang-Kum Stee (032560.KS)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.